|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/13 | (2006.01) |
| A61K 39/145 | (2006.01) |
| (11) | Number of the document | 1951296 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06831855.9 |
| Date of filing the European patent application | 2006-11-01 | |
| (97) | Date of publication of the European application | 2008-08-06 |
| (45) | Date of publication and mention of the grant of the patent | 2011-01-12 |
| (46) | Date of publication of the claims translation | 2011-05-25 |
| (86) | Number | PCT/IB2006/003880 |
| Date | 2006-11-01 |
| (87) | Number | WO 2007/052163 |
| Date | 2007-05-10 |
| (30) | Number | Date | Country code |
| 732786 P | 2005-11-01 | US |
| (72) |
GREGERSEN, Jens-Peter, DE
KOST, Holger, DE
|
| (73) |
Novartis Vaccines and Diagnostics GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ląstelių kilmės virusinės vakcinos, turinčios žemą likutinį ląstelių DNR lygį |
| CELL-DERIVED VIRAL VACCINES WITH LOW LEVELS OF RESIDUAL CELL DNA |
| Payment date | Validity (years) | Amount | |
| 2012-10-16 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2013-11-01 |